Mouse models of infection with Mtb

CC Catherine Y. Cheng
NG Nuria M. Gutierrez
MM Mardiana B. Marzuki
XL Xiaohua Lu
TF Taylor W. Foreman
BP Bhairav Paleja
BL Bernett Lee
AB Akhila Balachander
JC Jinmiao Chen
LT Liana Tsenova
NK Natalia Kurepina
KT Karen W. W. Teng
KW Kim West
SM Smriti Mehra
FZ Francesca Zolezzi
MP Michael Poidinger
BK Barry Kreiswirth
DK Deepak Kaushal
HK Hardy Kornfeld
EN Evan W. Newell
AS Amit Singhal
request Request a Protocol
ask Ask a question
Favorite

The antitubercular activity of SRT and RES was evaluated in an acute and chronic infection model of C57BL/6 mice (12). Female C57BL/6 mice (6 to 8 weeks old) were infected aerosolly with Mtb H37Rv or Erdman. Three to four animals were sacrificed on day 1 to determine the number of bacteria implanted in the lungs. Treatment was initiated 7 or 40 days after infection in the acute and chronic model, respectively. Drugs were administered by gavage once a day, 6 days a week. Mice were sacrificed at predetermined time points followed by harvesting of tissues and enumeration of Mtb CFU. A total of seven experiments (five acute and two chronic) were performed. All mice were housed in a biosafety level 3 (BSL3) laboratory and treated humanely. The Mac-SIRT1 KO mice (30) were a gift from X. Li (U.S. National Institute of Environmental Health Sciences). A total of three experiments were performed with Mac-SIRT1 KO and their littermate controls.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A